Medicxi Ventures Management as of Sept. 30, 2025
Portfolio Holdings for Medicxi Ventures Management
Medicxi Ventures Management holds 5 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 65.0 | $484M | 20M | 24.25 | |
| Phathom Pharmaceuticals (PHAT) | 11.8 | $88M | 7.5M | 11.77 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 11.0 | $82M | 2.9M | 28.44 | |
| Rapt Therapeutics | 9.7 | $72M | 2.8M | 25.79 | |
| Aura Biosciences (AURA) | 2.5 | $19M | 3.0M | 6.18 |
